Ardalan Behel, | |
5601 Wilshire Blvd, Los Angeles, CA 90036-3701 | |
(323) 936-0050 | |
Not Available |
Full Name | Ardalan Behel |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 5601 Wilshire Blvd, Los Angeles, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043634736 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | RPH60483 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ardalan Behel, 5601 Wilshire Blvd, Los Angeles, CA 90036-3701 Ph: () - | Ardalan Behel, 5601 Wilshire Blvd, Los Angeles, CA 90036-3701 Ph: (323) 936-0050 |
News Archive
An exploration of the molecular links between insulin resistance and inflammation may have revealed a novel target for diabetes treatment, say scientists at the John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh of UPMC. Their findings were published earlier this month in the online version of Diabetes, one of the journals of the American Diabetes Association.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has received gross proceeds of approximately $7.5 million in a private placement offering to institutional and accredited investors. In connection with the closing, the Company issued approximately 10.0 million shares of its convertible preferred stock and warrants to purchase approximately 5.0 million shares of its common stock at an exercise price of $1.00 per share.
A group of Swiss researchers headed by Prof. Sylvia Schneider has published a groundbreaking study on treatment of separation anxiety in the current issue of Psychotherapy and Psychosomatics.
Repros Therapeutics Inc. today announced that the Company has received the FDA's version of the minutes of the Type C meeting held on January 25, 2010. The minutes confirmed the Company's interpretation of the points the Agency made during the meeting. In correspondence from the FDA prior to the meeting the Agency noted that they could not currently agree with the Company's stated indication for the use of Androxal® in the treatment of secondary hypogonadism in men wishing to preserve fertility.
› Verified 7 days ago
Robert W Cheung, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3550 S La Brea Ave, Los Angeles, CA 90016 Phone: 323-293-9397 | |
Mrs. Afaf Guirguis Karanany, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4044 Eagle Rock Blvd, Los Angeles, CA 90065 Phone: 323-254-8642 | |
Dr. Stephanie Mary Liang Luo, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1520 San Pablo St, Los Angeles, CA 90089 Phone: 213-486-8652 | |
Mr. Benjamin S Kaster, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11340 Iowa Ave Apt 8, Los Angeles, CA 90025 Phone: 310-478-6179 Fax: 310-478-6179 | |
Sarah Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11321 National Blvd, Los Angeles, CA 90064 Phone: 310-479-5729 | |
Linda Han, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6041 Cadillac Ave, Kaiser West Los Angeles Medical Center, Los Angeles, CA 90034 Phone: 323-857-3989 | |
Dr. John Ball, PHARMACIST (PHARMD) Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3400 Whittier Blvd, Los Angeles, CA 90023 Phone: 562-773-3285 Fax: 323-268-1940 |